glp 1 compounding ending Out of Shortage, Into Controversy: The Fight Over GLP-1 What Patients Need to Know

We keep up multiple production batches to make sure there is always a supply, and we have set up emergency supply methods to handle pressing needs well

On time and product is great I feel super amazing

Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder

A brave new world of RNA-binding proteins

Individuals with significant liver disease, kidney disease, active cancer, or complex medical conditions should discuss potential risks and benefits with their healthcare team before considering compounded peptide therapy